Rising US Measles Cases Drive Urgent Push to Develop Antiviral Treatments

The United States is experiencing its highest measles case count in decades, prompting growing concern among health experts. Declining vaccination rates are being cited as a key driver behind the resurgence of the once-controlled disease. In response, researchers are actively working to develop drug-based treatments for those who become infected. These therapeutics are also being designed to protect individuals who are especially vulnerable to severe illness. The push marks a significant shift, as measles was previously managed almost entirely through vaccination rather than treatment.